APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gemcitabine Powder For Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gemcitabine Powder For Injection Industry Growth and Trends Forecast to 2032

2 January 202697 pages

Choose your research edition.

Industry ResearchGemcitabine Powder For Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gemcitabine Powder For Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Gemcitabine Powder For Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gemcitabine Powder For Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Gemcitabine Powder For Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gemcitabine Powder For Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gemcitabine Powder For Injection include Jiangsu Hansoh Pharmaceutical Group, Pfizer, Harbin Pharmaceutical Group, Strides Pharma Science Limited, Getwell Pharmaceuticals, Eli Lilly and Company, DRUG INTERNATIONAL LTD and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gemcitabine Powder For Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gemcitabine Powder For Injection market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gemcitabine Powder For Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gemcitabine Powder For Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gemcitabine Powder For Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gemcitabine Powder For Injection Market by Company

Jiangsu Hansoh Pharmaceutical Group

Pfizer

Harbin Pharmaceutical Group

Strides Pharma Science Limited

Getwell Pharmaceuticals

Eli Lilly and Company

DRUG INTERNATIONAL LTD

Accord Healthcare

Gemcitabine Powder For Injection Segment by Type

1 g

2 g

200 mg

Gemcitabine Powder For Injection Segment by Application

Geriatric Use

Pediatric Use

Adult Use

Gemcitabine Powder For Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gemcitabine Powder For Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gemcitabine Powder For Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gemcitabine Powder For Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gemcitabine Powder For Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gemcitabine Powder For Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1 g Table 2. Major Company of 2 g Table 3. Major Company of 200 mg Table 4. Global Gemcitabine Powder For Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gemcitabine Powder For Injection Sales by Type (2021-2026) & (Tons) Table 6. Global Gemcitabine Powder For Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Gemcitabine Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Gemcitabine Powder For Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Gemcitabine Powder For Injection Price by Type (2021-2026) & (US$/Kg) Table 10. Global Gemcitabine Powder For Injection Sales by Type (2027-2032) & (Tons) Table 11. Global Gemcitabine Powder For Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Gemcitabine Powder For Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Gemcitabine Powder For Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Gemcitabine Powder For Injection Price by Type (2027-2032) & (US$/Kg) Table 15. North America Gemcitabine Powder For Injection Sales by Type (2021-2026) & (Tons) Table 16. North America Gemcitabine Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Gemcitabine Powder For Injection Sales by Type (2021-2026) & (Tons) Table 18. Europe Gemcitabine Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Gemcitabine Powder For Injection Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Gemcitabine Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Gemcitabine Powder For Injection Sales by Type (2021-2026) & (Tons) Table 22. Latin America Gemcitabine Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Gemcitabine Powder For Injection Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Gemcitabine Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Gemcitabine Powder For Injection Industry Trends Table 26. Gemcitabine Powder For Injection Industry Drivers Table 27. Gemcitabine Powder For Injection Industry Opportunities and Challenges Table 28. Gemcitabine Powder For Injection Industry Restraints Table 29. Global Gemcitabine Powder For Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Gemcitabine Powder For Injection Revenue Market Share by Company (2021-2026) Table 31. Global Gemcitabine Powder For Injection Sales by Company (2021-2026) & (Tons) Table 32. Global Gemcitabine Powder For Injection Sales Share by Company (2021-2026) Table 33. Global Gemcitabine Powder For Injection Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Gemcitabine Powder For Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Gemcitabine Powder For Injection Major Company Production Sites and Headquarters Table 36. Global Gemcitabine Powder For Injection Company, Product Type & Application Table 37. Global Gemcitabine Powder For Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Gemcitabine Powder For Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Gemcitabine Powder For Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Gemcitabine Powder For Injection Sales by Region (2021-2026) & (Tons) Table 42. Global Gemcitabine Powder For Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Gemcitabine Powder For Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Gemcitabine Powder For Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Gemcitabine Powder For Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Gemcitabine Powder For Injection Sales by Region (2027-2032) & (Tons) Table 47. Global Gemcitabine Powder For Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Gemcitabine Powder For Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Gemcitabine Powder For Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Gemcitabine Powder For Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Gemcitabine Powder For Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Gemcitabine Powder For Injection Sales by Application (2021-2026) & (Tons) Table 53. Global Gemcitabine Powder For Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Gemcitabine Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Gemcitabine Powder For Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Gemcitabine Powder For Injection Price by Application (2021-2026) & (US$/Kg) Table 57. Global Gemcitabine Powder For Injection Sales by Application (2027-2032) & (Tons) Table 58. Global Gemcitabine Powder For Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Gemcitabine Powder For Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Gemcitabine Powder For Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Gemcitabine Powder For Injection Price by Application (2027-2032) & (US$/Kg) Table 62. North America Gemcitabine Powder For Injection Sales by Application (2021-2026) & (Tons) Table 63. North America Gemcitabine Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Gemcitabine Powder For Injection Sales by Application (2021-2026) & (Tons) Table 65. Europe Gemcitabine Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Gemcitabine Powder For Injection Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Gemcitabine Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Gemcitabine Powder For Injection Sales by Application (2021-2026) & (Tons) Table 69. Latin America Gemcitabine Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Gemcitabine Powder For Injection Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Gemcitabine Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Jiangsu Hansoh Pharmaceutical Group Company Information Table 73. Jiangsu Hansoh Pharmaceutical Group Business Overview Table 74. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Product Portfolio Table 76. Jiangsu Hansoh Pharmaceutical Group Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Pfizer Gemcitabine Powder For Injection Product Portfolio Table 81. Pfizer Recent Development Table 82. Harbin Pharmaceutical Group Company Information Table 83. Harbin Pharmaceutical Group Business Overview Table 84. Harbin Pharmaceutical Group Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Harbin Pharmaceutical Group Gemcitabine Powder For Injection Product Portfolio Table 86. Harbin Pharmaceutical Group Recent Development Table 87. Strides Pharma Science Limited Company Information Table 88. Strides Pharma Science Limited Business Overview Table 89. Strides Pharma Science Limited Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Strides Pharma Science Limited Gemcitabine Powder For Injection Product Portfolio Table 91. Strides Pharma Science Limited Recent Development Table 92. Getwell Pharmaceuticals Company Information Table 93. Getwell Pharmaceuticals Business Overview Table 94. Getwell Pharmaceuticals Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Getwell Pharmaceuticals Gemcitabine Powder For Injection Product Portfolio Table 96. Getwell Pharmaceuticals Recent Development Table 97. Eli Lilly and Company Company Information Table 98. Eli Lilly and Company Business Overview Table 99. Eli Lilly and Company Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Eli Lilly and Company Gemcitabine Powder For Injection Product Portfolio Table 101. Eli Lilly and Company Recent Development Table 102. DRUG INTERNATIONAL LTD Company Information Table 103. DRUG INTERNATIONAL LTD Business Overview Table 104. DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Product Portfolio Table 106. DRUG INTERNATIONAL LTD Recent Development Table 107. Accord Healthcare Company Information Table 108. Accord Healthcare Business Overview Table 109. Accord Healthcare Gemcitabine Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Accord Healthcare Gemcitabine Powder For Injection Product Portfolio Table 111. Accord Healthcare Recent Development Table 112. North America Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 113. North America Gemcitabine Powder For Injection Sales by Country (2021-2026) & (Tons) Table 114. North America Gemcitabine Powder For Injection Sales Market Share by Country (2021-2026) Table 115. North America Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 116. North America Gemcitabine Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 117. North America Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Gemcitabine Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Gemcitabine Powder For Injection Market Share by Country (2021-2026) Table 120. North America Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Gemcitabine Powder For Injection Market Share Forecast by Country (2027-2032) Table 122. Europe Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 123. Europe Gemcitabine Powder For Injection Sales by Country (2021-2026) & (Tons) Table 124. Europe Gemcitabine Powder For Injection Sales Market Share by Country (2021-2026) Table 125. Europe Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 126. Europe Gemcitabine Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Gemcitabine Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Gemcitabine Powder For Injection Market Share by Country (2021-2026) Table 130. Europe Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Gemcitabine Powder For Injection Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Gemcitabine Powder For Injection Sales by Country (2021-2026) & (Tons) Table 134. Asia-Pacific Gemcitabine Powder For Injection Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 136. Asia-Pacific Gemcitabine Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Gemcitabine Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Gemcitabine Powder For Injection Market Share by Country (2021-2026) Table 140. Asia-Pacific Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Gemcitabine Powder For Injection Market Share Forecast by Country (2027-2032) Table 142. Latin America Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 143. Latin America Gemcitabine Powder For Injection Sales by Country (2021-2026) & (Tons) Table 144. Latin America Gemcitabine Powder For Injection Sales Market Share by Country (2021-2026) Table 145. Latin America Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 146. Latin America Gemcitabine Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Gemcitabine Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Gemcitabine Powder For Injection Market Share by Country (2021-2026) Table 150. Latin America Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Gemcitabine Powder For Injection Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2021-2026) & (Tons) Table 154. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 156. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Gemcitabine Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Gemcitabine Powder For Injection Market Share by Country (2021-2026) Table 160. Middle East and Africa Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Gemcitabine Powder For Injection Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Gemcitabine Powder For Injection Distributors List Table 165. Gemcitabine Powder For Injection Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Gemcitabine Powder For Injection Image Figure 2. Global Gemcitabine Powder For Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gemcitabine Powder For Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Gemcitabine Powder For Injection Sales (2021-2032) & (Tons) Figure 5. 1 g Image Figure 6. Global 1 g Sales YoY Growth (2021-2032) & (Tons) Figure 7. 2 g Image Figure 8. Global 2 g Sales YoY Growth (2021-2032) & (Tons) Figure 9. 200 mg Image Figure 10. Global 200 mg Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Gemcitabine Powder For Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Gemcitabine Powder For Injection Market Share by Type 2025 VS 2032 Figure 13. North America Gemcitabine Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Gemcitabine Powder For Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Gemcitabine Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Gemcitabine Powder For Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Gemcitabine Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Gemcitabine Powder For Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Gemcitabine Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Gemcitabine Powder For Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Gemcitabine Powder For Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Geriatric Use Image Figure 26. Global Geriatric Use Sales YoY Growth (2021-2032) & (Tons) Figure 27. Pediatric Use Image Figure 28. Global Pediatric Use Sales YoY Growth (2021-2032) & (Tons) Figure 29. Adult Use Image Figure 30. Global Adult Use Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Gemcitabine Powder For Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Gemcitabine Powder For Injection Market Share by Application 2025 VS 2032 Figure 33. North America Gemcitabine Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Gemcitabine Powder For Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Gemcitabine Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Gemcitabine Powder For Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Gemcitabine Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Gemcitabine Powder For Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Gemcitabine Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Gemcitabine Powder For Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Gemcitabine Powder For Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Gemcitabine Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Gemcitabine Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Gemcitabine Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Gemcitabine Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gemcitabine Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Gemcitabine Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gemcitabine Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Gemcitabine Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gemcitabine Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Gemcitabine Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gemcitabine Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Gemcitabine Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gemcitabine Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Gemcitabine Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gemcitabine Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Gemcitabine Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gemcitabine Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Gemcitabine Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gemcitabine Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Gemcitabine Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Gemcitabine Powder For Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Gemcitabine Powder For Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1 g
  • 2 g
  • 200 mg
Applications
  • Geriatric Use
  • Pediatric Use
  • Adult Use
Companies covered
  • Jiangsu Hansoh Pharmaceutical Group
  • Pfizer
  • Harbin Pharmaceutical Group
  • Strides Pharma Science Limited
  • Getwell Pharmaceuticals
  • Eli Lilly and Company
  • DRUG INTERNATIONAL LTD
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gemcitabine Powder For Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gemcitabine Powder For Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gemcitabine Powder For Injection Market by Type
  6. 1.3.1 1 g
  7. 1.3.2 2 g
  8. 1.3.3 200 mg
  9. 1.4 Global Gemcitabine Powder For Injection Market Size by Type
  10. 1.4.1 Global Gemcitabine Powder For Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Gemcitabine Powder For Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Gemcitabine Powder For Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Gemcitabine Powder For Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Gemcitabine Powder For Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Gemcitabine Powder For Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Gemcitabine Powder For Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Gemcitabine Powder For Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gemcitabine Powder For Injection Industry Trends
  2. 2.2 Gemcitabine Powder For Injection Industry Drivers
  3. 2.3 Gemcitabine Powder For Injection Industry Opportunities and Challenges
  4. 2.4 Gemcitabine Powder For Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gemcitabine Powder For Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Gemcitabine Powder For Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Gemcitabine Powder For Injection Price (2021-2026)
  4. 3.4 Global Gemcitabine Powder For Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gemcitabine Powder For Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Gemcitabine Powder For Injection Company, Product Type & Application
  7. 3.7 Global Gemcitabine Powder For Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gemcitabine Powder For Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gemcitabine Powder For Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gemcitabine Powder For Injection Tier 1, Tier 2, and Tier 3
4 Gemcitabine Powder For Injection Regional Status and Outlook
  1. 4.1 Global Gemcitabine Powder For Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gemcitabine Powder For Injection Historic Market Size by Region
  3. 4.2.1 Global Gemcitabine Powder For Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gemcitabine Powder For Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gemcitabine Powder For Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gemcitabine Powder For Injection Forecasted Market Size by Region
  7. 4.3.1 Global Gemcitabine Powder For Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gemcitabine Powder For Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gemcitabine Powder For Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gemcitabine Powder For Injection by Application
  1. 5.1 Gemcitabine Powder For Injection Market by Application
  2. 5.1.1 Geriatric Use
  3. 5.1.2 Pediatric Use
  4. 5.1.3 Adult Use
  5. 5.2 Global Gemcitabine Powder For Injection Market Size by Application
  6. 5.2.1 Global Gemcitabine Powder For Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gemcitabine Powder For Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gemcitabine Powder For Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gemcitabine Powder For Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gemcitabine Powder For Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gemcitabine Powder For Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gemcitabine Powder For Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gemcitabine Powder For Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jiangsu Hansoh Pharmaceutical Group
  2. 6.1.1 Jiangsu Hansoh Pharmaceutical Group Company Information
  3. 6.1.2 Jiangsu Hansoh Pharmaceutical Group Business Overview
  4. 6.1.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Product Portfolio
  6. 6.1.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Gemcitabine Powder For Injection Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Harbin Pharmaceutical Group
  14. 6.3.1 Harbin Pharmaceutical Group Company Information
  15. 6.3.2 Harbin Pharmaceutical Group Business Overview
  16. 6.3.3 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Product Portfolio
  18. 6.3.5 Harbin Pharmaceutical Group Recent Developments
  19. 6.4 Strides Pharma Science Limited
  20. 6.4.1 Strides Pharma Science Limited Company Information
  21. 6.4.2 Strides Pharma Science Limited Business Overview
  22. 6.4.3 Strides Pharma Science Limited Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Strides Pharma Science Limited Gemcitabine Powder For Injection Product Portfolio
  24. 6.4.5 Strides Pharma Science Limited Recent Developments
  25. 6.5 Getwell Pharmaceuticals
  26. 6.5.1 Getwell Pharmaceuticals Company Information
  27. 6.5.2 Getwell Pharmaceuticals Business Overview
  28. 6.5.3 Getwell Pharmaceuticals Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Getwell Pharmaceuticals Gemcitabine Powder For Injection Product Portfolio
  30. 6.5.5 Getwell Pharmaceuticals Recent Developments
  31. 6.6 Eli Lilly and Company
  32. 6.6.1 Eli Lilly and Company Company Information
  33. 6.6.2 Eli Lilly and Company Business Overview
  34. 6.6.3 Eli Lilly and Company Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly and Company Gemcitabine Powder For Injection Product Portfolio
  36. 6.6.5 Eli Lilly and Company Recent Developments
  37. 6.7 DRUG INTERNATIONAL LTD
  38. 6.7.1 DRUG INTERNATIONAL LTD Company Information
  39. 6.7.2 DRUG INTERNATIONAL LTD Business Overview
  40. 6.7.3 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Product Portfolio
  42. 6.7.5 DRUG INTERNATIONAL LTD Recent Developments
  43. 6.8 Accord Healthcare
  44. 6.8.1 Accord Healthcare Company Information
  45. 6.8.2 Accord Healthcare Business Overview
  46. 6.8.3 Accord Healthcare Gemcitabine Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Accord Healthcare Gemcitabine Powder For Injection Product Portfolio
  48. 6.8.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Gemcitabine Powder For Injection Sales by Country
  2. 7.1.1 North America Gemcitabine Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gemcitabine Powder For Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gemcitabine Powder For Injection Market Size by Country
  6. 7.2.1 North America Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gemcitabine Powder For Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gemcitabine Powder For Injection Sales by Country
  2. 8.1.1 Europe Gemcitabine Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gemcitabine Powder For Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gemcitabine Powder For Injection Market Size by Country
  6. 8.2.1 Europe Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gemcitabine Powder For Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gemcitabine Powder For Injection Sales by Country
  2. 9.1.1 Asia-Pacific Gemcitabine Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gemcitabine Powder For Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gemcitabine Powder For Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gemcitabine Powder For Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gemcitabine Powder For Injection Sales by Country
  2. 10.1.1 South America Gemcitabine Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gemcitabine Powder For Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gemcitabine Powder For Injection Market Size by Country
  6. 10.2.1 South America Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gemcitabine Powder For Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gemcitabine Powder For Injection Sales by Country
  2. 11.1.1 Middle East and Africa Gemcitabine Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gemcitabine Powder For Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gemcitabine Powder For Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Gemcitabine Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gemcitabine Powder For Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gemcitabine Powder For Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gemcitabine Powder For Injection Value Chain Analysis
  2. 12.1.1 Gemcitabine Powder For Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gemcitabine Powder For Injection Production Mode & Process
  7. 12.2 Gemcitabine Powder For Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gemcitabine Powder For Injection Distributors
  10. 12.2.3 Gemcitabine Powder For Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst